Tumour type (primary and recurrent), tumour grade, sex, age, LGG diagnosis type, TP53 mutation status, IDH1 R132 mutation status, EGFR mutation status, ATRX mutation status and PTEN mutation status were used to evaluate the independence of the DMlncRNA signature in predicting prognosis. The gene discussed is PTEN; the disease is neoplasm.